Stocks and InvestingStocks and Investing
Fri, April 16, 2021
Thu, April 15, 2021
Wed, April 14, 2021
Tue, April 13, 2021

Matthew Harrison Maintained (TSHA) at Buy with Increased Target to $43 on, Apr 13th, 2021


Published on 2024-10-27 16:12:41 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Buy with Increased Target from $30 to $43 on, Apr 13th, 2021.

Matthew has made no other calls on TSHA in the last 4 months.



There are 2 other peers that have a rating on TSHA. Out of the 2 peers that are also analyzing TSHA, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Raju Prasad of "William Blair" Initiated at Buy and Held Target at $46 on, Wednesday, February 24th, 2021
  • Kevin DeGeeter of "Oppenheimer" Initiated at Buy on, Tuesday, January 5th, 2021